Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Conmed (CNMD) Revenue (2016 - 2026)

Conmed filings provide 17 years of Revenue readings, the most recent being $317.0 million for Q1 2026.

  • On a quarterly basis, Revenue fell 1.31% to $317.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 billion, a 4.14% increase, with the full-year FY2025 number at $1.4 billion, up 5.18% from a year prior.
  • Revenue hit $317.0 million in Q1 2026 for Conmed, down from $373.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $373.2 million in Q4 2025 to a low of $242.3 million in Q1 2022.
  • Median Revenue over the past 5 years was $317.0 million (2026), compared with a mean of $311.1 million.
  • Biggest five-year swings in Revenue: decreased 8.43% in 2022 and later surged 30.37% in 2023.
  • Conmed's Revenue stood at $250.9 million in 2022, then skyrocketed by 30.37% to $327.0 million in 2023, then grew by 5.78% to $345.9 million in 2024, then grew by 7.88% to $373.2 million in 2025, then dropped by 15.05% to $317.0 million in 2026.
  • The last three reported values for Revenue were $317.0 million (Q1 2026), $373.2 million (Q4 2025), and $337.9 million (Q3 2025) per Business Quant data.